Emcure Pharmaceuticals gets SEBI's go-ahead to launch IPO

15 Dec 2021 Evaluate

Emcure Pharmaceuticals has received the Securities and Exchange Board of India’s (SEBI) approval to float an initial public offering (IPO). The IPO comprises fresh issuance of equity shares worth Rs 1,100 crore and offer of sale (OFS) of 18,168,356 equity shares by promoters and existing shareholders. The shares of the company are proposed to be listed on both BSE and NSE.

The company, which filed the draft red herring prospectus with the SEBI in August, got the regulator’s approval on December 8, 2021. Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes. Axis Capital, JM Financial, BOB Capital Markets, BofA Securities India, Credit Suisse Securities (India) are the book running lead managers to the issue.

Emcure Pharmaceuticals is engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.

Emcure Pharma Share Price

1117.20 62.30 (5.91%)
03-Apr-2025 09:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1770.10
Dr. Reddys Lab 1151.25
Cipla 1495.15
Lupin 2094.50
Zydus Lifesciences 901.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...